A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.
from WebMD Health https://ift.tt/D8alR0q
Tuesday, 6 June 2023
Targeted Drug May Lower Odds for Breast Cancer's Return in Some Patients
from WebMD Health https://ift.tt/D8alR0q
0 comments:
Post a Comment